CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Lipid modification - primary and secondary CVD prevention - Management
What are the cautions and contraindications for statins?
- Do not prescribe a statin in:
- People with active liver disease or unexplained persistent elevations of serum transaminases.
- Women who are pregnant or breastfeeding.
- Do not initiate a statin in:
- People with transaminase levels that are three or more times the upper limit of normal:
- People within the first 48 hours of an acute stroke.
- Seek specialist advice before initiating a statin in people with a history of haemorrhagic stroke, particularly those with inadequately controlled hypertension.
Basis for recommendation
© NHS Institute for Innovation and Improvement